Quality of life and sexuality in chronic dialysis female patients

International Journal of Impotence Research

Volumn 18, Issue 6, 2006, Pages 539-543

  Coelho Marques, F Z ^a   Wagner, M B ^a   Poli De Figueiredo, C E ^a   D'Avila, D O ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dialysis; End stage kidney disease; Quality of life; Sexual dysfunction; Sexuality; Uremia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; KIDNEY FAILURE; MARRIAGE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

CHRONIC DISEASE; DIALYSIS; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 33750457970     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901470     Document Type: Article

References (27)

1. The World Health Organization Quality of Life Assessment (WHOQOL). Position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-1409.
2. Skevington SM, O'Connell KA, The WHOQOL Group. Can we identify the poorest quality of life? Assessing the importance of quality of life using the WHOQOL-100. Qual Life Res 2004; 13: 23-24.
3. McInnes RA. Chronic illness and sexuality. Med J Aust 2003; 179: 263-266.
4. Cerqueira J, Moraes M, Glina S. Erectile dysfunction: prevalence and associated variables in patients with chronic renal failure. Int J Impot Res 2002; 14: 65-71.
5. Manns B, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol 2003; 60: 341-351.
6. Perneger TV, Leski M, Chopard-Stoermann C, Martin PY. Assessment of health status in chronic hemodialysis patients. J Nephrol 2003; 16: 252-259.
7. Nolan CR. Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol 2005; 16(Suppl 2): S120-S127.
8. Silver J, Levi R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int 2005; 67(Suppl 95): S8-S12.
9. Robinson BM, Joffe MM, Berns JS, Pisoni RL, Port FK, Feldman HI. Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney Int 2005; 68: 2323-2330.
10. Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyren O et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Swedden. Am J Kidney Dis 2005; 46: 863-870.
11. Diemont WL, Vruggink PA, Meuleman EJ, Doesburg WH, Lemmens WA, Berden JH. SD after renal replacement therapy. Am J Kidney Dis 2000; 35: 845-851.
12. Seibel I, Poli de Figueiredo CE, Telöken C, Moraes JF. Efficacy of oral sildenafil in hemodialysis patientes with erectile disfunction. J Am Soc Nephrol 2002; 13: 2770-2775.
13. Alleyne S, Dillard P, McGregor C, Hosten A. A Sexual function and mental distress status of patients with end-stage renal disease on hemodialysis. Transplant Proc 1989; 21: 3895-3898.
14. Steele TE, Wuerth D, Finkelstein S, Juergensen D, Juergensen P, Kliger AS et al. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol 1996; 7: 1165-1168.
15. Milde FK, Hart LK, Fearing MO. Sexuality and fertility concerns of dialysis patients. ANNA J 1996; 23: 307-315.
16. Mastrogiacomo I, De Besi L, Serafini E, Zussa S, Zucchetta P, Romagnoli GF et al. Hyperprolactinemia and sexual disturbances among uremic women on hemodialysis. Nephron 1984; 37: 195-199.
17. Schaefer RM, Kokot F, Keurner B, Zech M, Heidland A. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin (r-HuEPO). Int J Artif Organs 1989; 12: 445-449.
18. Weizman R, Weizman A, Levi J, Gura V, Zevin D, Maoz B et al. Sexual dysfunction associated with hyperprolactinemia in males end females undergoing hemodialysis. Psychosom Med 1983; 45: 259-269.
19. Yeksan M, Tamer N, Cirit M, Turk S, Akhan G, Akkus I et al. Effect of r-HuEPO therapy on plasma FT3, FT4, TSH, FSH, LH, free testosterone and prolactine levels in hemodialysis patients. Int J Artif Organs 1992; 15: 585-589.
20. Palmer BF. Sexual dysfunction in men and woman with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther 2003; 10: 48-60.
21. Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol 1999; 10: 1381-1388.
22. Kurella M, Ireland C, Hlatky M, Shlipak MG, Yaffe K, Hulley SB et al. Physical and sexual function in women with chronic kidney disease. Am J Kidney Dis 2004; 43: 868-876.
23. Zimmermann PR, Poli de Figueiredo CE, Fonseca NA. Depression, anxiety and adjustment in renal replacement therapy: a quality of life assessment. Clin Nephrol 2001; 56: 387-390.
24. Fleck M, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida 'WHOQOL-bref'. Rev Saude Publica 2000; 34: 178-183.
25. The WHOQOL Group. Development of the World Health Orgaziation WHOQOL-bref quality of life assessment. Psychol Med 1998; 28: 551-558.
26. Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005; 65: 143-148.
27. Abdo CHN, Oliveira WM, Moreira Jr ED, Fittipaldi JAS. Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women - results of the Brazilian study on sexual behavior (BSSB). Int J Impot Res 2004; 16: 160-166.